Lymphocytic Leukemia Manufacturers, Suppliers & Companies
-
Technologybased in Paramus, NEW JERSEY (USA)
Starton is an emerging clinical-stage biotechnology company transforming standard of care therapies with proprietary dermal delivery technology, so people with cancer can receive continuous treatment to live better, longer. Focused on continuous ...
Model STAR-LLD - Chronic Lymphocytic Leukemia (Cll)
STAR-LLD is in development in two continuous delivery systems: subcutaneous and transdermal. STAR-LLD is being developed to establish the only IMiD (immunomodulatory drug) approved for CLL. CLL is the most common form of leukemia. ...
CONTACT SUPPLIER -
Manufacturerbased in Mountain View, CALIFORNIA (USA)
Chronus Health, a Fogarty Innovation company, develops in-vitro point-of-care devices leveraging microfluidics and semiconductor technologies with a mission to reduce time-to-care and improve patient outcomes. Chronus Health's portable platform is ...
-
Manufacturerbased in Utrecht, NETHERLANDS
At LAVA, we are focused on applying our expertise in gamma-delta T cell engagers. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor ...
Lava - Model 051 - Pipeline
Our lead program, LAVA-051, is a unique, humanized gamma-delta bsTCE targeting CD1d-expressing tumors, including multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
We believe we are entering a new era of medicine. The ability to modify genes and use cells as medicines provides new tools to meaningfully change the outcome of many human diseases. Early pioneers have made good progress, but most of what we can ...
Sana - Model SC291 (CD19) - T cells - Hypoimmune Technology: Donor-derived
Oncology: Non-Hodgkin lymphoma (NHL), Acute lymphoblastic leukemia (ALL), Chronic lymphocytic leukemia ...
CONTACT SUPPLIER -
Manufacturerbased in Hayward, CALIFORNIA (USA)
Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays through innovation. Our signature technology platform is a proprietary polymer-based detection system. Based on this technology we have developed a series of highly ...
Novodiax - Model CD45 Ab - Antibody for Body Fluid & FNA
in the activation of those cells (a form of co-stimulation). It is expressed in Lymphomas, B-cell Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, and Acute Non-lymphocytic ...
CONTACT SUPPLIER -
Manufacturerbased in Woodcliff Lake, NEW JERSEY (USA)
Eagle is a specialty pharmaceutical company working to advance safe and efficient injectable treatments for patients across oncology, critical care, and orphan diseases. At Eagle, we are committed to developing innovative drugs that result in ...
Bendeka - Bendamustine Hydrochloride Injection
Indications: BENDEKA® is indicated for the treatment of patients with Chronic lymphocytic leukemia (CLL). Efficacy relative to first-line therapies other than chlorambucil has not been established. Indolent ...
CONTACT SUPPLIER -
Manufacturerbased in Planegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tafasitamab - Model MOR208 - Humanized FC-Modified CD19 Targeting Immunotherapy
large B cell lymphoma (DLBCL), indolent lymphomas like follicular lymphoma (FL) and marginal zone lymphomas (MZL), as well as chronic lymphocytic leukemia (CLL). The main development focus of tafasitamab (MOR208) ...
CONTACT SUPPLIER -
Manufacturerbased in Orlando, FLORIDA (USA)
InteGen LLC was founded in 2011 by an experienced board-certified clinical cytogeneticist to address the challenges often faced by the cytogeneticists in their clinical practice. InteGen develops innovative FISH probes that are clinically useful and ...
InteGen - Multiplex ALL-1 Probe
and structural abnormalities related to B- and T-cell Acute Lymphocytic Leukemia ...
CONTACT SUPPLIER -
Manufacturerbased in Shanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
Henlius HANLIKANG - Rituximab Injection
-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis for which the originator rituximab has not been approved in China, benefiting a wider patient population with differentiated ...
CONTACT SUPPLIER -
Manufacturerbased in Seocho-gu, SOUTH KOREA
Taking the first step in 1945, JW Group has found the market for domestic therapeutic drug based on its philosophy of respecting life and pioneering spirit. We are strengthening our global market competitiveness by developing leading health care ...
Alkyloxan - Cyclophosphamide Tablet
Active Ingredients: cyclophosphamide 50mg per 1 ...
CONTACT SUPPLIER -
Manufacturerbased in San Diego, CALIFORNIA (USA)
Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells. To ...
Model FT596 - T Cells Engineered with Chimeric Antigen Receptors (CARs)
T cells engineered with chimeric antigen receptors (CARs) have shown exceptional promise as a potentially curative therapy for patients with certain hematologic malignancies. While most researchers and clinical investigators continue to focus on the ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you